Fecal Microbiota Transplantation & Cholangitis

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

 

Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.

 

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story.

 

Liver-Microbiome Axis in Health and Disease.

 

Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.

 

New Therapeutic Targets in Autoimmune Cholangiopathies.

 

Intestinal microbiota in primary sclerosing cholangitis.

 

Gut microbiome in primary sclerosing cholangitis: A review.

 

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

 

Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.

 

Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.

 

The Microbiome and Primary Sclerosing Cholangitis.

 

Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

 

New Therapeutic Strategies for Primary Sclerosing Cholangitis.

 

Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.

 

Emerging pharmacologic therapies for primary sclerosing cholangitis.

 

Emerging treatments for primary sclerosing cholangitis.